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Objective: Postoperative ileus (POI) is an inflammation-mediated complication of
abdominal surgery, characterized by intestinal dysmotility and leukocyte infiltration into
the muscularis externa (ME). Previous studies indicated that interleukin (IL)-10 is crucial
for the resolution of a variety of inflammation-driven diseases. Herein, we investigated
how IL-10 affects the postoperative ME inflammation and found an unforeseen role of
IL-10 in POI.
Design: POI was induced by a standardized intestinal manipulation (IM) in C57BL/6
and multiple transgenic mouse strain including C-C motif chemokine receptor 2−/−, IL-
10−/−, and LysMcre/IL-10fl/fl mice. Leukocyte infiltration, gene and protein expression
of cytokines, chemokines, and macrophage differentiation markers as well as intestinal
motility were analyzed. IL-10 serum levels in surgical patients were determined by ELISA.
Results: IL-10 serum levels were increased in patient after abdominal surgery. In
mice, a complete or leucocyte-restricted IL-10 deficiency ameliorated POI and reduced
the postoperative ME neutrophil infiltration. Infiltrating monocytes were identified as
main IL-10 producers and undergo IL-10-dependent M2 polarization. Interestingly, M2
polarization is not crucial to POI development as abrogation of monocyte infiltration did
not prevent POI due to a compensation of the IL-10 loss by resident macrophages
and neutrophils. Organ culture studies demonstrated that IL-10 deficiency impeded
neutrophil migration toward the surgically traumatized ME. This mechanism is mediated
by reduction of neutrophil attracting chemokines.
Conclusion: Monocyte-derived macrophages are the major IL-10 source during POI.
An IL-10 deficiency decreases the postoperative expression of neutrophil-recruiting
chemokines, consequently reduces the neutrophil extravasation into the postsurgical
bowel wall, and finally protects mice from POI.
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INTRODUCTION
Postoperative ileus (POI) is a common sequela of abdominal surgery and is characterized
by gastrointestinal dysmotility. POI is associated with increased morbidity and prolonged
hospitalization, subsequently leading to a significant medico-economic burden (1). The intensity of
the operative trauma was shown to correlate with the duration of POI in rodents and humans (2–4).
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Previous work of our group and others demonstrated that POI
originates from an inflammation of the muscularis externa (ME)
that is triggered by activation of resident macrophages (5) and
enteric glia (6). The inflammatory course can be separated
into an early and a late phase. The early manifestation phase
involves the local production of pro-inflammatory mediators,
including interleukin (IL)-1α/β, IL-6, tumor necrosis factor alpha
(TNF-α), monocyte chemokine ligand (CCL)-2, or kinetic active
mediators like nitric oxide that all aggravate the inflammation
and abrogate smooth muscle contractility (7, 8). This phase
is followed by a cell infiltration, particularly by blood-derived
monocytes and neutrophils (2, 9–11). Therefore, modulation
of the underlying immune response to the surgical trauma
has become an important target opening new avenues for
preventive or therapeutic measures (12). While POI in general is
a self-limiting disease, patients often suffer from prolonged POI
which majorly affects patient’s recovery after abdominal surgery.
Although themechanisms of prolonged POI are unknown, it may
depend on an insufficient counter-regulation that may lead to
an overwhelming and prolonged inflammation. Recent studies
suggest that pro-resolving lipidmediators are involved (13) in the
resolution of POI but also anti-inflammatory cytokines have been
hypothesized to be involved (14).
Inflammation resolving mechanisms were often described
to involve M2 macrophage polarization which substantially
differ from the proinflammatory M1 phenotype (15, 16).
M2 macrophages promote resolution of inflammation and
wound healing and express higher levels of Arginase 1
(Arg1), transforming growth factor (TGF)-β, and IL-10 (17, 18).
Prominent mediators that drive M2 polarization are IL-4 (15)
and IL-10 (19–21). A previous study has shown that IL-10
recombinant IL-10 reduced POI in mice (14) but the mechanism
behind remained elusive. Herein, we hypothesized that IL-10may
affect POI by triggering M2 macrophage. Indeed we found that
IL-10 plays a crucial role in M2 macrophage polarization but
strikingly, we identified an unforeseen role of IL-10 in different
transgenic mouse lines which challenges our pervious knowledge
about its role during POI development. Mechanistically, this
role depends on an alteration of neutrophil recruitment to the
surgically manipulated site of the bowel.
MATERIALS AND METHODS
Animals
Experiments were performed with WT 8- to 12-week-old
male C57BL6/J mice (Janvier, Saint Berthevin Cedex, France)
with a mean body weight of 20–25 g. Additionally, CCR2−/−,
ITIB+/− (22), IL10−/−, IL4−/−LysMcre/IL10flfl, and LysMcre-
TdTomatoSTOPfl/fl mice were used. CCR2-, IL-10-, and IL-
4-deficient mice were obtained from Jackson Laboratories
(Charles River, Sulzfeld, Germany). LysMcre-TdTomatoSTOPfl/fl
mice were kindly provided by Prof. Irmgard Förster (LIMES
Institute, University of Bonn). All experiments were performed
Abbreviations: Arg, Arginase; GIT, gastrointestinal tract; IL, interleukin; IM,
intestinal manipulation; ME, muscularis externa; MPO, myeloperoxidase; POI,
postoperative ileus.
in accordance to federal law for animal protection and approved
by proper authorities of North-Rhine-Westfalia (LANUV),
file numbers 87-51.04.2010-A091, 87-51.04.2010-A284, 84-
02.04.2013.A162, and 84-02.04.2013.A104.
Patients
IL-10 serum concentrations were quantified by an IL-10 Elisa
(R&D Systems, Wiesbaden, Germany) in 24 patients of which
17 underwent open abdominal and 7 underwent extraabdominal
surgery. Blood samples were taken before and 24 h after
surgery. Patients were recruited from the University Hospital
Bonn during the BiPOI trial which was registered at the
German Clinical Trial Register, file DRKS00000736. The study
protocol (#065/11) was approved by the ethical committee of
the University of Bonn and all patients gave written informed
consent in accordance with the Declaration of Helsinki.
Operative Procedures
The small intestine of mice was mechanically manipulated in a
standardized manner as described previously (2). Briefly, after
laparotomy the small bowel was eventrated and manipulated
by two moisted cotton tips from oral to aboral direction. After
intestinal manipulation (IM), the intestine was placed back and
the abdomen closed by a two layer suture. Control animals did
not undergo IM.
Flow Cytometry Analyses
Small bowel ME immunocytes were isolated by enzymatically
digestion of the ME with 0.1% Collagenase type II (Worthington,
New York, USA) diluted in HBSS containing 0.1 mg/mL DNase
I (La Roche, Mannheim, Germany), 2.4 mg/mL Dispase II
(La Roche), 1 mg/mL BSA (Applichem, Darmstadt, Germany),
and 0.7 mg/mL Trypsin inhibitor (Applichem) for 35min in
a 37◦C shaking water bath. Afterwards the cell suspension
was filtered through 70µm gauze and single cells were
analyzed by flow cytometry. ITIB+/− mice express beta-
lactamase together with IL-10 under control of the endogenous
IL-10 promotor. Cells from ITIB+/− and control littermate
mice were resuspended in a CCF4-AM staining solution
(CCF4, Life Technologies, Darmstadt, Germany), according
to the manufacturer’s instructions before, washed with FACS
buffer (PBS, 1% FBS, and 2mM EDTA) and subjected to
immunofluorescence staining. Fluorescence resonance energy
transfer of CCF4-AM was used to visualize IL-10 production at
single-cell level (Supplementary Figure 1A). For all cell analyses,
Fc-blocking solution (clone 2.4G2) was incubated for 20min
and cells further stained for 30min at 4◦C with fluorochrome-
labeled monoclonal antibodies against CD45, F4/80, Ly6C, and
Ly6G (see Supplementary Table 2). Gating strategies included
exclusion of dead cells [Hoechst-33342+ (Sigma)], Zombie
NIRTM solution or Propidium Iodide, respectively, doublet and
CD45− cells. Additional gating strategies are mentioned in the
figure legends. Flow cytometry analyses were performed on a
FACS Canto II (BD Biosystems, Heidelberg, Germany) and data
analyzed with FlowJo software (Tree Star Inc., Ashland, USA).
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Cell Sorting
For each cell sort, ME tissue of 12 mice was pooled. The
extraction of ME immunocytes was done as described above.
Bone marrow derived monocytes and neutrophils were isolated
by flushing the bone marrow cells out of femur and tibia with
ice-cold PBS by using a 25-gauge needle. In another approach,
immunocytes from the ME of 2–3 WT or IL10−/− naïve mice
were isolated like described above and CD45+F4/80+ resident
macrophages were sorted. Samples were acquired and sorted
by using FACS Diva software (BD Biosciences, Heidelberg,
Germany) on FACS Aria flow cytometer (BD Biosciences,
Heidelberg, Germany).
Arginase Activity
Arginase activity was evaluated in mouse ME tissue as described
before (23). Results were specified as urea produced per hour per
100mg tissue.
Tissue Culture and Determination of IL-10
Release in Supernatant
POI was induced in WT, CCR2−/−, IL4−/−, and IL10−/−
and LysMcreIL10fl/fl mice and the ME harvested 24 h after
manipulation. The isolated muscularis (50mg) was incubated
(37◦C, 5% CO2) in 6-well tissue culture plates within 500 µL
of DMEM. After 24 h, cell-free supernatant was collected and
stored at−80◦C. IL-10 release from these ME organ cultures was
measured by a commercial ELISA (BD Biosciences, Heidelberg,
Germany). The given results were normalized to pg/100mg ME
tissue.
IL-10 Reconstitution in LysMcreIL10/ Mice
POI was induced in 8–10 weeks old LysMcreIL10fl/fl mice and
rmIL-10 (1,000 ng/250 µL sterile PBS, Biolegend, Germany)
was injected intraperitoneally 3 h after IM. Twenty-four hours
after manipulation MPO+ cells, GIT, and cell infiltration were
determined.
Neutrophil Transmigration Assay
Bone marrow neutrophils were isolated from naïve WT mice
as described before (24). 105 neutrophils were resuspended
in 100 µL RPMI 1% FCS and placed into the upper chamber
of a Transwell insert (6.5mm, 3µm pore, polycarbonate
membrane, Corning Incorporated, New York, USA) in
triplicates. The lower chamber contained RPMI 1% FCS
supplemented with 20% of cell-free supernatant gained
from 24 h ME incubation of unmanipulated WT or IL-
10−/− mice (10mg ME/100 µL RPMI), respectively. In a
second approach the lower chamber contained RPMI 1% FCS
supplemented with 10 or 100 ng/mL rmIL-10 (ImmunoTools,
Germany). The cells were incubated for 3 h at 37◦C in 5%
CO2. Cells, which migrated from the upper to the lower
chamber through the filter, were collected and counted by a
hemocytometer.
Measurement of Gastrointestinal Transit
(GIT)
GIT was measured 24 h after IM. Animals were gavaged
with a FITC-labeled dextran solution (size 70 kDa; Sigma-
Aldrich, Steinheim, Germany) 22.5 h after IM. Ninety minutes
later, the complete GI tract was harvested and divided into
15 segments (stomach–colon) and FITC dextran contents
were fluorometrically determined in each segment. The
geometric center (GC) was calculated as described previously
by distribution of the FITC-labeled dextran using this formula:
GC =
∑
(% of total fluorescent signal per segment ∗ segment
number)/100.
Quantitative RT-PCR
Total RNA of ME tissue samples were extracted using
Trizol (Life Technologies, Darmstadt, Germany) according
to manufacturer’s instructions. Sorted cells were extracted
using PicoPure Isolation RNA kit (Thermo Fischer Scientific,
Germany). Complementary DNA was synthesized using the
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Darmstadt, Germany). Expression of mRNA was
quantified in triplicates by a RT-PCR with exon-spanning
primers, Quantitect primer assay (Qiagen), or TaqMan probes
(Supplementary Table 1) and SYBR Green PCR Master Mix or
the TaqMan Gene Expression Master Mix (Applied Biosystems)
were used for the PCR.
Histochemical and Immunofluorescence
Analysis
Midjejunal, ME whole mounts were fixed in ethanol for 10min
and underwent an staining of myeloperoxidase (MPO)+ cells for
10min with 1 mg/ml Hanker Yates reagent (Polysciences Europe,
Hamburg, Germany) in PBS containing 0.3% H2O2. MPO
+ cells
were counted in five randomly chosen areas and calculated as
MPO+ cells/mm2.
In some experiments ME whole mounts from C57BL6/L or
LysMcre-TdTomatoSTOPfl/fl underwent 4% paraformaldehyde
fixation for 30min, were blocked with 3% bovine serum
albumin in PBS, permeabilized by 0.2% Triton-X 100, and
were incubated with either anti-MHC-II or anti-F4/80 or anti-
Arg1 antibodies overnight followed (Supplementary Table 2) by
incubation with FITC- or Cy3-coupled secondary IgG antibodies
(Dianova, Hamburg, Germany, 1:1,600 diluted). Confocal laser
scanning microscopy (Zeiss, LSM 700, Oberkochen, Germany)
was used for analysis. MPO and MHCII analyses in LysMcre-
TdTomatoSTOPfl/fl mice were performed with a TE2000
microscope (Nikon, Düsseldorf, Germany).
Statistical Analysis
Statistical analysis was performed with Prism V5.04 (GraphPad,
San Diego, CA) using unpaired Student’s t-test or one-way or
multivariate ANOVA as indicated followed by Bonferroni’s post-
hoc test. Levels of significance were indicated as p < 0.05 (∗), p
< 0.01(∗∗), and p < 0.01(∗). The statistical methods used in each
analyses are mentioned in the figure legends.
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RESULTS
Leukocyte Restricted IL-10 Deficiency
Limits Inflammation and Neutrophil
Extravasation in POI
IL-10 is described as a cytokine with anti-inflammatory
properties. In the present manuscript we describe an unforeseen
detrimental role of IL-10 in the pathogenesis of POI.
In order to analyze whether IL-10 is involved in POI we
first analyzed its gene expression in a time course of POI.
After IM, IL-10 was more than 35-fold upregulated in the
ME (Figure 1A) compared to control mice. IL-10 protein
was also increased in supernatants of postoperative ME organ
cultures (Figure 1B) taken from animals 24 h after IM while
IL-10 was absent in IL-10−/− mice, confirming the correct
genotype of these mice and specificity of the ELISA. In patients
that underwent open abdominal surgery, we also observed
an increase in postoperative IL-10 serum levels (Figure 1C)
while patients with extraabdominal surgery did not exhibit
elevated IL-10 levels. From these findings, we hypothesized that
IL-10 may be involved in POI pathophysiology and resolution
and determined GI transit time and leukocyte extravasation
in IL-10−/−mice. Unexpectedly, we observed a significantly
improved GI-transit 24 h after surgery in IL-10−/−mice
compared to WT animals. No differences in transit time were
observed at day 3 and 7 in IL-10−/−mice (Figure 1D). The
functional data were supported by reduced numbers of MPO+
leukocytes 24 h after IM (Figure 1E), which majorly consist of
Ly6C+Ly6G− monocytes (84%) and Ly6C+Ly6G+ neutrophils
(13%) (Supplementary Figure 1A). Interestingly, these findings
are contradictory to previous data that described delayed
recovery from POI and even death at day 7 after IM (14). As huge
variety of cell types is able to produce IL-10 we subjected mice
with a leukocyte-restricted IL-10 deficiency to IM. Conditional
targeting was achieved by use of LysM-cre recombinase
mice (25). A pilot experiment revealed LysM expression
FIGURE 1 | The role of IL-10 in POI. WT and IL-10−/− mice underwent IM or left untreated (CTL). (A) Gene expression of IL-10 was analyzed in WT mice after
indicated time points and compared to naïve controls (CTL). n = 5 mice per group. Statistical analysis was done by one-way ANOVA followed by Bonferroni’s
post-hoc test (***p < 0.001). (B) IL-10 release into the media of 24 h organ cultured ME harvested from intestinal manipulated (IM24h) WT or IL-10−/− mice. Groups
were compared by one-way ANOVA followed by Bonferroni’s post-hoc test (**p < 0.01 and ***p < 0.001 vs. control or indicated groups; n.d. not detected). Bar
graphs demonstrate means ± SEM, n = 4 for both groups. (C) IL-10 human serum concentrations were measured in surgical patients who underwent abdominal
(AS, n = 17) and extraabdominal (EAS, n = 7) surgery before and 24 h after surgery. Data sets are shown as means ± SEM and were compared via a paired t-test.
(D) GI-transit was plotted as mean ± SEM calculated by the geometric center of distribution of a fluid meal. st, stomach, c, cecum. Bar graphs show means ± SEM
and are representative for five independent experiments. (E) MPO+ cells were quantified in naïve and 24, 72, and 168 h after IM in WT and IL-10−/− mice. Cells were
microscopically counted in five randomly chosen areas in ME whole mount specimens. Statistical analysis was performed by one-way ANOVA followed by
Bonferroni’s post-hoc test (***p < 0.001 vs. CTL or indicated groups).
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in MHC-II+ resident muscularis macrophages in naïve
LysMcreTdTomatoSTOPfl/fl mice (Supplementary Figure 1B).
After IM, LysM-cre expression was detected in almost all living
CD45+ infiltrating Ly6C+ monocytes also Ly6G+ neutrophils
and more than 60% of the resident F4/80+Ly6C− macrophages
(Supplementary Figure 1B). Given that LysM-cre mice indeed
exhibit cre-recombinase activity in leukocytes, we next crossbred
them to IL-10fl/fl and subjected the LysMcreIL10fl/fl littermates
to our POI model. Remarkably, LysMcreIL10fl/fl mice showed a
similar outcome as pan-IL-10 deficient mice with a normalized
GI-transit (GC: 8.6 ± 1.8) 24 h after IM compared to WT
mice (Figure 2A) and significantly reduced MPO+ leukocyte
counts (Figure 2B). As expected, the IM-induced increase in
IL-10 gene expression was not observed in LysMcreIL10fl/fl mice
(Figure 2C). Further characterization of the LysMcreIL10fl/fl
inflammatory infiltrate revealed a more than 40% reduction in
Ly6C+Ly6G+ neutrophils compared to WT mice (Figure 2D).
Simultaneously, Ly6C+Ly6G−monocytes were slightly increased
in LysMcreIL10fl/fl mice.
As IL-10 deficiency attenuated POI in two independent mouse
strains we concluded that IL-10 deficiency protects mice from
POI. In turn, an application of exogenous IL-10 to these mice
should restore the POI phenotype observed in WT mice and
impair the postoperative outcome of IL-10 deficientmice. Indeed,
recombinant IL-10 administration reversed the improved POI
phenotype of LysMcreIL10fl/fl mice which developed a regular
POI as shown by a decelerated GI transit time and increased
MPO+ leukocyte influx (Figures 2E,F). In line with the
reduction of neutrophils in LysMcreIL10fl/fl, recombinant IL-
10 administration increased the number of neutrophils but not
monocytes (Figure 2G).
IL-10 Is Mainly Produced by Monocytes
and Macrophages During POI
We next aimed to specify the cellular source of IL-10 by
use of ITIB mice, a sensitive IL-10 reporter mouse strain
(Supplementary Figure 2A) (22). In naïve ITIB+/− mice, IL-
10 was expressed within 7.2% ± 1.5 of the ME cells
(Figures 3Ai,B) of which almost all were CD45+ leukocytes
(98.97% ± 0.6). Of those, 36.8% ± 4.6 were F4/80+Ly6C−
resident macrophages and 59.4%± 5.6 Ly6C+ Ly6G−monocytes
(Figure 3Aii). Ly6C+Ly6G+ neutrophils were absent in naïve
mice (Figure 3Aiii). The total number of IL-10+ cells was
increased at 24 h (20.8% ± 4.5) and 72 h (14.8% ± 1.5)
after surgery (Figure 3Ai). Although F4/80+Ly6C−macrophages
were among IL-10+ cells (2.2% ± 0.5), infiltrating monocytes
were the predominant IL-10 expressing cell population 24 h
after IM (92.1% ± 0.9, Figure 3Aiii,3B). After 72 h, the
F4/80+Ly6C−IL-10+ mature macrophage population consisting
of resident ME macrophages and macrophages descendants
of the Ly6C+ monocytes, increased (39.6% ± 2.2). Ly6G+IL-
10+ neutrophils increased to 6.0% ± 0.9 but decreased at
72 h (3.3% ± 0.1, Figure 3Aiii,B). Additionally, gene expression
analyses of postoperatively sorted monocytes, neutrophils
and macrophages confirmed abundant IL-10 gene expression
in infiltrated monocytes compared to bone marrow-derived
monocytes. This upregulation was not observed in sorted ME
neutrophils (compared to bone marrow derived neutrophils)
nor in resident ME macrophages (Figure 3C). Taken together,
these data show that infiltrating F4/80+Ly6C+ monocytes are the
predominant source of IL-10 during POI.
Next we were wondering if an elimination of this IL-10
source would also affect POI. Recently, monocyte infiltration
during POI was shown to depend on CCR2 (26, 27). Consistent
with these data, F4/80+Ly6C+ cells were almost absent in
CCR2−/− (1.8% ± 0.8) compared to WT mice (62% ± 1.7)
24 h after IM (Supplementary Figure 3A) while F4/80+Ly6C−
resident macrophages were not affected by CCR2 deficiency
(Supplementary Figure 3B). Surprisingly, CCR2−/− and WT
mice demonstrated the same extent of motility disturbances
24 h after IM (GC: 4.1 ± 0.6 and 4.1 ± 0.4, respectively,
Supplementary Figure 3C). Surprisingly, postoperative ME
IL-10 protein levels were not reduced but even increased
in CCR2−/− mice (Supplementary Figure 3D), indicating
that compensatory mechanisms encounter the IL-10 loss in
monocytes. A comparison of CCR2-deficient ITIB+/− and
CCR-2 competent ITIB+/− mice demonstrated that the numbers
of IL-10 producing resident macrophages and neutrophils
increased, indicating that these cells compensate the IL-10 loss in
monocytes (Supplementary Figure 3E).
M2 Polarization Is Driven by IL-10 but Does
Not Affect POI
IL-10 triggers M2 polarization of macrophages. Therefore, we
analyzed if M2 polarization occurs and affects POI. In WT
mice, Arg1 and Ym1 mRNA expression was increased and
peaked 24 h after IM (Figure 4A). Accordingly, the ME arginase
activity was also increased up to 72 h after IM (Figure 4B).
To characterize the cells undergoing M2 polarization during
POI, we microscopically identified numerous F4/80+ round-
shaped monocytes in the postoperative ME (Figure 4C). Arg1
immunoreactivity was rarely found in F4/80+ stellate-shaped
resident macrophages. Quantitative PCR of sortedME leukocytes
confirmed elevated Arg1 expression in infiltrating F4/80+Ly6C+
monocyte-derived macrophages (Figure 4D, group 3) compared
to F4/80+Ly6C− resident macrophages from naïve (group 1)
and intestinally manipulated mice (group 2). Arg-1 expression
did not differ between group 1 and 2. In line with these
findings, CCR2−/− mice, lacking F4/80+Ly6C+ monocyte-
derived macrophages, as well as IL-10−/− and LysMcreIL10fl/fl
mice demonstrated strongly reduced postoperative Arg1 and
Ym1 mRNA levels compared to WT mice (Figure 4E).
Furthermore, MEmacrophages of naïve IL-10−/−mice exhibited
a pro-inflammatory gene expression profile in comparison to
WT mice (Supplementary Figure 4). Notably, we did not detect
any signs of ME leukocyte infiltration in naïve ME (Figure 1E),
confirming that IL-10 deficient mice, known to spontaneously
develop colitis at a certain age, exhibit no basal inflammation
in the ME. We subsume that IL-10 triggers M2 polarization of
naïve resident macrophages and infiltrating monocyte-derived
macrophages during POI.
Finally we analyzed of IL-13 or IL-4, two other prototypical
M2 polarization-triggering cytokines may also be involved in
POI. IL-13 transcripts were only slightly elevated (∼3-fold) in
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FIGURE 2 | Leukocyte restricted IL-10 deficiency limits inflammation and neutrophil extravasation in POI. WT and LysMcre/IL10fl/fl mice underwent IM. (A) GI-transit
was plotted as mean ± SEM calculated by the geometric centers of distribution of a fluorescent marker. st, stomach, c, cecum. Bar graphs show means ± SEM and
are representative for five independent experiments. (B) Quantification of MPO+ cells within the same animals used in (A). Statistical analysis was performed with a
one-way ANOVA followed by Bonferroni’s post-hoc test (***p < 0.001 vs. CTL or indicated groups). (C) Gene expression analysis of IL-10 was performed 24 h after IM
and compared to naïve controls (CTL). Data are shown as mean fold change ± SEM in mRNA levels vs. CTL. n = 5 for all groups. ***p < 0.001 vs. strain-specific CTL
or between indicated samples. Statistical analysis was done by one-way ANOVA followed by Bonferroni’s post-hoc test. (D) Flow cytometry analysis of ME specimen
was performed to identify Ly6G−Ly6C+ monocytes and Ly6G+Ly6C+ neutrophils 24 h after IM in WT and LysMcre/IL10fl/fl mice. Data sets are shown as mean fold
change ± SEM, n = 5 for all groups. Statistical significance between mouse strains was determined by unpaired t-test (**p < 0.01 vs. indicated samples). (E–G)
LysMcre/IL10fl/fl mice were treated with rmIL-10 or vehicle after IM. GI-transit (D), MPO+ cells (E), and flow cytometry analysis (F) of ME specimen was performed as
described above. Data sets (n = 4) were compared by unpaired t-test (*p < 0.05, **p < 0.01 vs. vehicle treated group).
the early phase of POI (Supplementary Figure 4B) and IL-4 was
not detected in the naïve or postoperative ME but in the spleen
(Supplementary Figure 4B). However, a previous study detected
ME IL-4 transcripts (27). To ensure that we did not overlook
IL-4-driven effects we subjected IL-4−/− mice to IM. Neither
Arg1 activity nor MPO+ leukocyte counts or GI transit differed
between WT and IL-4−/− mice (Supplementary Figures 4C–E),
indicating that IL-4 is not involved in M2 polarization during
POI. Mice with a deficiency in IL13 signaling were not available
to us.
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FIGURE 3 | IL-10 is mainly produced by monocytes and macrophages during POI. (A) ITIB+/− mice underwent IM or left untreated (CTL). After 24 and 72 h, IL-10
reporter activity was detected by a CCF4 administration resulting in blue fluorescence. Gating on living IL-10+ cells (i) was followed by CD45+ as well as identification
of F4/80+/Ly6C+/− (ii) and Ly6C+Ly6G+/− (iii) cell populations during flow cytometry analysis. Data are representative plots from three independent experiments.
(B) Ratios of IL-10+CD45+ cells within the ME of CTL and intestinally manipulated WT mice. Data are shown as means ± SEM, n = 3 for all groups. (C) Resident
F4/80+Ly6C− macrophages, Ly6C+Ly6G− monocytes, and Ly6C+Ly6G+ neutrophils were sorted by flow cytometry from CTL and IM24 h animals, respectively.
Indicated cell populations underwent gene expression analysis of IL10. n = 3 for all groups. Statistical analysis was done by one-way ANOVA followed by Bonferroni’s
post-hoc test. **p < 0.01 vs. CTL.
Neutrophil Transmigration Is Impaired by
IL-10 Deficiency
In order to further identify the mechanism by which IL-
10 deficiency ameliorates POI we spend attention on the
significantly reduced neutrophil numbers in IL-10−/− and
LysMcreIL10fl/fl mice. Postoperatively, we sorted extravasated
neutrophils, monocytes and resident ME macrophages
and neutrophils demonstrated a more than 1,700-fold
increased IL-10Rα gene expression compared to naïve bone
marrow neutrophils. The infiltrated monocytes and resident
macrophages did not upregulate IL-10Rα compared to bone
marrow-derived monocytes or resident ME macrophages from
naïve animals (Figure 5A). Interestingly, we also observed
a reduced transmigration of WT neutrophils to the site of
traumatized ME organ culture supernatants from IL-10 deficient
mice compared to WT mice (Figure 5B). We hypothesized
that IL-10 may directly affect neutrophil migration and
compared toward recombinant IL-10 directly. Neither 10 nor
100 ng/ml IL-10 altered the number of migrating neutrophils
(Figure 5C), indicating that IL-10 indirectly affects neutrophil.
As neutrophil recruitment requires chemotaxis we quantified
mRNA of prototypical neutrophil attracting chemokines in
the ME. In contrast to WT mice, the neutrophil attracting
chemokines CXCL1 and CXCL2 decreased 24 h after IM in
LysMcreIL10fl/fl mice, whereas CCL2 increased under IL-10
deficiency (Figure 5D). These findings suggest that IL-10 affects
neutrophil migration to traumatized sites via regulation of
neutrophil chemokine expression.
Overall our results identified a so unforeseen role for IL-
10 in POI’s pathogenesis wherein IL-10 triggers neutrophil
extravasation to the surgically manipulated bowel and
ameliorates POI.
DISCUSSION
Resolution of POI is crucial for the recovery of patients
undergoing abdominal surgery. Leukocyte recruitment into the
intestinal ME has been shown to be a hallmark of POI in rodents,
swine, and humans (5, 27). Another study demonstrated that IL-
10 is involved in the resolution of POI (6) and we hypothesized
that the infiltrating leukocytes could be amajor source or target of
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FIGURE 4 | IL-10 is mainly produced by monocytes and macrophages during POI. (A) Arginase 1 (Arg1) and Ym1 mRNA levels were analyzed in WT mice after
indicated time points. n = 5 mice per group. (B) Arginase activity was determined by urea formation within the same ME specimens used in (A). (C) Confocal
microscopy of F4/80 and Arg1 expressing cells 24 h after IM in the ME of WT mice. Asterisks, resident F4/80+/Arg1− muscularis macrophages; arrows, infiltrated
F4/80+Arg1+ monocytes. Note the presence of numerous Arg1+ monocyte-shaped cells not yet expressing F4/80. Shown are representative images from three
independent experiments. Scale = 50µm. (D) Three different cell populations (1–3) were sorted by flow cytometry from CTL and IM24h animals. Populations were
defined as F4/80+Ly6C− resident macrophages (1, CTL green; 2, IM24h red) and F4/80+Ly6C+ monocytes (3, IM24h blue). Indicated cell populations underwent
gene expression analysis of Arg1 and Ym1. n = 3 for all groups. Statistical analysis was done by one-way ANOVA followed by Bonferroni’s post-hoc test. *p < 0.05
and **p < 0.01 vs. group 1. (E) Gene expression of Arg1 and Ym1 was analyzed 24 h postoperatively in WT and CCR2−/− mice. Data are shown as changes in
mRNA levels (means ± SEM) compared to non-manipulated strain specific controls. Groups (n = 5) were compared via unpaired t-test (***p < 0.001).
IL-10 and might induce and/or undergo M2 polarization which
contributes to healing processes and finally resolution of POI.
A time course of IL-10 gene expression indicated that IL-
10 is upregulated within the first 24 h and might play a role
in the early phase. This finding is in line with a previous
study of 10 patients, demonstrating an early increase of IL-10
within 4 h after major abdominal (28). Our present results
demonstrate that serum levels from patient undergoing open
abdominal but not from patients with extraabdominal surgery
are still significantly increased 24 h after surgery. Of note, the
abdominal surgery group showed a significantly higher recovery
time from POI than the extraabdominal surgery group (29).
This indicates that IL-10 might modulate the postoperative
immune response during, particularly in the first 24 h. However,
a previous study demonstrated no effect of IL-10 deficiency 24 h
after surgery but observed an impairment in POI resolution at
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FIGURE 5 | Neutrophil transmigration is impaired by IL-10 deficiency. (A) Resident F4/80+Ly6C− macrophages, Ly6C+Ly6G− monocytes and Ly6C+Ly6G+
neutrophils were sorted by flow cytometry from CTL and IM24h animals, respectively. Indicated cell populations underwent gene expression analysis of IL-10Rα. n = 3
for all groups. Statistical analysis was done by one-way ANOVA followed by Bonferroni’s post-hoc test. ***p < 0.001 vs. CTL or indicated populations. (B) Neutrophil
transmigration was determined toward WT ME or IL-10−/− ME conditioned media (SN, supernatant). Data are shown as mean fold change ± SEM. n = 4 for both
groups. Statistical significance was determined by unpaired t-test (**p < 0.01 vs. WT SN). (C) Analysis of neutrophil transmigration through a microporous membrane.
Bone marrow derived WT neutrophils were cultured in triplicates in a transwell culture system and where were allowed to transmigrate toward IL-10 supplemented
media (10, 100 ng/mL) or medium (Veh). No significance was determined between vehicle and IL-10 supplemented groups. (D) WT and LysMcre/IL10fl/fl mice
underwent IM and qPCR analysis of neutrophil chemokines CXCL1/CXCL2 as well as monocyte chemokine CCL2 was performed 24 h after IM and compared to
naïve controls (CTL). Data are shown as mean fold change ± SEM in mRNA levels vs. CTL. n = 5 for all groups. *p < 0.05; **p < 0.01; ***p < 0.001 vs. strain-specific
CTL or between indicated samples. Statistical analysis was done by one-way ANOVA followed by Bonferroni’s post-hoc test.
later time points and even observed death of IL-10−/− in the
postoperative phase (6). Therefore, we repeated this experiment
and subjected IL-10−/− mice to IM. Surprisingly, we found
that IL-10−/− mice did not exhibit a delayed resolution but
rather demonstrated an accelerated GI transit. Beneficial effects
of an IL-10 deficiency have also observed in a model of surgical
skin wounding skin (30). The sharp difference between these
previous findings by Stoffels et al. and our data prompted us to
subject LysMcreIL10fl/fl mice to IM and they exhibited exactly
the same phenotype like the IL-10−/− animals did in our hands.
The LysM-driven restriction of IL-10 deficiency was chosen as
monocytes, monocyte-derived macrophages, and neutrophils are
the predominant infiltrating cell types indicating that they might
be the major IL-10 source or target in POI. LysMcreIL10fl/fl mice
(25) have been shown to be deficient of IL-10 in leukocytes in
naïve mice and other inflammatory disease models (31–33). By
use of LysMcre-TdTomatoSTOPfl/fl mice we confirmed leukocyte
restriction to infiltrating leucocytes and resident macrophages
of the ME. The striking differences to Stoffels’s et al. findings
may be explained by technical reasons. While we used a single
intraperitoneal injection of 40 µg/kg BW 3h after IM, Stoffels
et al. used two subcutaneous injections, 1 h prior and 1 h after
IM, each with 125 µg/kg BW of recombinant IL-10. Another
reason for this divergence could be the different application time
points of IL-10. Previous studies suggested that IL-10-mediated
effects are time dependent as IL-10 neutralization at the time of
a cecal ligation and puncture (CLP)-induced sepsis increased the
sepsis-induced mortality (34). However, lethality decreased when
IL-10 was neutralized after CLP (35). These studies confirm the
divergent data regarding the protective or harmful roles of IL-10.
However, as we observed the same phenotype in two independent
IL-10 deficient mouse models (IL-10−/− and LysMcreIL10fl/fl
mice) we conclude that IL-10 has a detrimental role, at least in
the late phase of POI, as administration of recombinant IL-10 3 h
after IM restored the regular POI phenotype.
As our data indicate that IL-10 aggravates POI, we aimed to
gain more insight into the mechanism behind this unexpected
effect. By the use of the ITIB IL-10 reporter mice (22) we
identified infiltrating monocyte-derived macrophages as the
major IL-10 producers in the postoperative ME after 24 h while
resident muscularis macrophages are the exclusive IL-10 source
in the naïve ME. The cellular sources could be confirmed
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by gene expression studies of flow cytometry sorted cells of
WT mice which exhibited the highest expression of IL-10 in
monocyte derived macrophages. We further demonstrated that
the F4/80+Ly6C+ cell population predominantly undergoes M2
polarization as it exhibits a strong Arg1 and Ym1 expression
after IM and that the M2 marker expression depends on IL-
10 which is known to drive M2 polarization also in other
inflammatory diseases (36, 37). Notably, IL-4 and IL13 (19, 20,
38, 39), were either not present or much lower upregulated
after IM, respectively. Although we did not detect any IL-
4 ME transcripts in a time course of up to 72 h after IM,
Engel et al. demonstrated a constant IL-4 expression in the
ME of naïve and intestinally manipulated mice (26) and Farro
et al. observed an IL-4 upregulation but only 12 h after IM
(27). This discrepancy may be based on contamination of the
ME specimen by submucosal tissue which is known to be
continuously express IL-4. However, although we clearly detected
IL-4 in the spleen, we could not exclude a higher sensitivity of
the quantitative PCR used in the other studies. To ensure that
we were not missing any effects of IL-4 on the postoperative M2
polarization, whichmay be present but technically not detectable,
we subjected IL-4−/− mice to IM and observed no difference in
ME arginase activity, leukocytes infiltration, and POI outcome
compared to WT animals. These data indicate that IL-10 is the
major M2 polarization driver during POI. However, our data
also indicate that IL-10 affects naïve resident ME macrophages
as naïve IL-10−/− mice showed an increased M1 polarization
signature. This is line with previous findings showing a higher
proinflammatory cytokine expression profile from IL-10 deficient
lamina propria macrophages under homeostasis (40). Of note,
this M1 signature does not originate from any infiltrating
leucocytes as no infiltrating leukocyte were present in the naïve
small bowel ME of both IL-10 deficient mouse strains. Only one
IL-10−/− mouse spontaneously developed colitis in an age of 10
weeks and was not included in our study. Mice with the LysM-
Cre driven leukocyte-restricted IL-10 deficiency were shown not
to spontaneously develop an enterocolitis. Therefore, the M1
signature of the naïve ME is highly likely induced by a missing
IL-10 ligation on resident macrophages that express higher levels
of proinflammatory cytokines.
As we identified monocyte-derived macrophages as the
major source but also as an important target of IL-10 during
POI, we spend further attention on this cell population. The
presence of monocytes in the blood, which are the precursors
of the F4/80+Ly6C+ cells of the postoperative ME, strictly
depends on CCR2 (41). Recently two independent publications
demonstrated that Ly6C+ monocyte ME infiltration during POI
is abolished in CCR2−/− mice (27, 42). We hypothesized that
an elimination of CCR2 dependent monocytes will also lead to
significant loss of IL-10 which may mimic the phenotype of
IL-10 deficient mice. In line with the previous studies we also
observed an almost complete abrogation of monocyte infiltration
by CCR2 deficiency. Confirmingly IL-10 producing Ly6C+
monocyte and their Ly6C+ F4/80+ macrophage descendants
were almost completely absent and Arg1 and Ym1 expression
were dramatically reduced. However, although the major IL-10
producing cell population was missing in CCR2−/− mice, IL-10
ME protein levels, determined by ELISA whose specificity was
confirmed in IL-10−/− mice (Figure 1B), were not reduced but
even increased in CCR2−/− mice. Additionally these mice did
not reveal any dysmotility 24 h after IM compared to wildtype
controls and this phenotype is in line with the findings from
Pohl et al. and Farro et al. (27, 42). It should be noted that
Farro et al. observed a delayed resolution of POI 72 h after
IM in CCR2−/− but we assume that this phenotype is not
linked to IL-10 as IL-10 gene expression is not increased in the
ME at this time point. Our data suggest that a compensatory
source of IL-10 was activated in CCR2−/− mice and resident
macrophages appear to be the most likely alternative source
as they produce IL-10 and express the IL-10R1 under basal
conditions. Of note, the resident macrophages may achieve this
compensatory function only in the absence of monocyte-derived
IL-10 as their numbers and their IL-10 gene expression rate
is not differing in naïve CCR2−/− and WT mice. Another
alternative source could be IL-10 producing neutrophils that
were increased in the postoperative ME of CCR2−/− mice.
Supportingly, neutrophils becomemore substantially activated in
CCR2−/− mice that underwent a Toxoplasma gondii infection
and also exhibited reduced monocyte numbers but no reduction
in neutrophil numbers (43).
Subsumed, IL-10 drives M2 macrophage polarization but this
seems not to be crucial to POI development as an absence of M2
macrophages in CCR2−/− mice did not affect POI. Nevertheless,
the question how IL-10 deficiency improves POI remains open.
To this end, further insight into the mechanism came from
flow cytometry characterization of the leukocyte ME infiltrate.
In both transgenic mouse models, the IL-10 deficiency led to
a reduction of neutrophils but not monocytes. This phenotype
could be reversed by administration of recombinant IL-10
treatment what increased the neutrophil influx in LysMcreIL-
10fl/fl mice and finally resulted in a normal POI development
as it was observed in WT mice. In line with other studies
(44, 45), IL-10 alone did not alter neutrophil transmigration in
vitro indicating that IL-10 does not act as neutrophil chemokine.
However, supernatants of traumatized ME specimens of IL-
10−/− mice, which were taken into organ culture after in
vivo manipulation, demonstrated a lower transmigration of
WT neutrophils toward surgically manipulated ME supernatant.
These findings indicate that IL-10 indirectly affects neutrophil
migration and a subsequent comparison of monocytes and
neutrophil chemokine expression uncovered a strong reduction
of the neutrophil chemokines CXCL1 and CXCL2 but not CCL2,
which attracts monocytes. Additionally, inactive neutrophils
contain an intracellular pool of the IL-10R that can be mobilized
to the cell surface after LPS, TNF-α, or granulocyte/monocyte-
colony stimulating factor stimulation (46). Those mediators
are also elevated in the postoperative ME (14, 47) and our
findings demonstrate a dramatically IM-induced increase in IL-
10Rα gene expression in flow-cytometry sorted ME neutrophils
but not in monocytes. As the before described neutrophil
functions and subcellular localization of the IL10-R can hardly
be described in vivo we can so far only speculate on this
direct function of IL-10 on neutrophils. To this end, IL-10
was shown to impair neutrophil metabolism and bactericidal
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functions, including phagocytosis and cytotoxicity (48–51).
IL-10 was also described to block neutrophil extracellular
trap (NET) formation in a model of HIV infection (52).
Although the exact mechanism remains to be identified, our
data clearly indicate an impairment of neutrophil attraction
by an IL-10 mediated reduction of neutrophil chemokine
expression.
Our data give new mechanistic insight into an unexpected
function of IL-10 in the pathogenesis of POI. However, clinically
a direct intervention in the IL-10 pathway may be consequently
become a treatment option as IL-10 has also been shown to
exert beneficial effects in a variety of diseases and its role in
human POI still has to be explored. Nevertheless, IL-10 could
be still an interesting target as a potential surrogate marker for
POI manifestation or prolongation and it would be interesting to
study if IL-10 serum levels remain upregulated or even increase
in patients with prolonged POI in comparison to patients without
a prolonged POI. Any further speculation on interventional
approaches in IL-10 signaling for prevention or treatment of POI
are—at this time—rather speculative than evidence-based and
additional studies are imperative.
Taken together, the present study demonstrates that IL-10 is
a double-edged sword in POI pathophysiology. Basically, IL-10
is mainly produced by resident muscularis macrophages and
shapes their polarization. Postoperatively, infiltrating monocyte-
derived macrophages emerge as the main IL-10 producers
and simultaneously drivers of M2 macrophage polarization.
However, while M2 polarization per se is not crucial to
POI resolution, IL-10 deficiency unexpectedly reduced the
postoperative motility disturbances. The underlying mechanisms
involve an IL-10-driven indirect alteration of neutrophil
migration in POI.
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